560,252 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Penn Capital Management Company LLC

Key Points

• Penn Capital Management opened a new position in Acadia Healthcare, buying 560,252 shares valued at about $15.4 million, or roughly 0.60% of the company.
• Acadia reported quarterly earnings of $0.60 per share, beating the $0.46 analyst consensus, while revenue of $895.3 million also exceeded estimates and rose 5.1% year over year.
• Analyst views remain mixed: MarketBeat reports a consensus “Hold” rating and a $32.54 price target, despite eight Buy ratings among 15 analysts.

Penn Capital Management Company LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 560,252 shares of the company's stock, valued at approximately $15,434,000. Penn Capital Management Company LLC owned about 0.60% of Acadia Healthcare at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Clough Capital Partners L P acquired a new stake in shares of Acadia Healthcare during the first quarter worth $5,359,000. Deutsche Bank AG purchased a new position in Acadia Healthcare in the 2nd quarter valued at $49,746,000. Bank of America Corp DE acquired a new position in Acadia Healthcare in the 2nd quarter valued at $21,606,000. Lisanti Capital Growth LLC acquired a new position in Acadia Healthcare in the 2nd quarter valued at $4,502,000. Finally, Royal Bank of Canada increased its stake in Acadia Healthcare by 7,896.1% in the 1st quarter. Royal Bank of Canada now owns 278,265 shares of the company's stock valued at $6,508,000 after buying an additional 274,785 shares during the period.

Acadia Healthcare Stock Up 4.4%

ACHC opened at $38.61 on Tuesday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $39.70. The stock has a market capitalization of $3.59 billion, a P/E ratio of -3.10, a P/E/G ratio of 10.39 and a beta of 0.64. The business has a 50 day simple moving average of $29.61 and a 200-day simple moving average of $26.26.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.14. The firm had revenue of $895.31 million for the quarter, compared to analyst estimates of $877.76 million. Acadia Healthcare had a positive return on equity of 6.58% and a negative net margin of 33.07%. Acadia Healthcare's quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.72 earnings per share. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 1.75 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ACHC has been the subject of a number of analyst reports. Raymond James Financial started coverage on shares of Acadia Healthcare in a research report on Wednesday, November 4th. They set a "moderate buy" rating for the company. Cantor Fitzgerald lifted their target price on shares of Acadia Healthcare from $30.00 to $39.00 and gave the company a "neutral" rating in a report on Friday. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Leerink Partners boosted their price target on shares of Acadia Healthcare from $30.00 to $33.00 and gave the stock a "market perform" rating in a research note on Wednesday, September 23rd. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $32.54.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care.

Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program.

Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.